연구성과로 돌아가기

2024 연구성과별 연구자 정보 (734 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Lee, Seung-Hwan Lee, SH 18 Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Coll Med,Div Endocrinol & Metab, Seoul, South Korea AAG-1361-2019 Lee, Seung-Hwan leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Park, Keun-Young Park, KY 19 Konyang Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Daejeon, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Rhee, Sang Youl Rhee, SY 20 Kyung Hee Univ, Kyung Hee Univ Hosp, Coll Med, Dept Endocrinol & Metab, Seoul, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, Sin Gon Kim, SG 21 Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Anam Hosp, Seoul, South Korea KQU-7757-2024 Kim, Sin Gon 0000-0002-7430-3675 Kim, Sin Gon leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Park, Seok Park, S 22 Gwangmyeong Sungae Hosp, Dept Internal Med, Div Endocrinol & Metab, Gwangmyeong, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, Dae Jung Kim, DJ 23 Ajou Univ, Ajou Univ Hosp, Dept Internal Med, Div Endocrinol & Metab,Sch Med, Suwon, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, Byung Joon Kim, BJ 24 Gachon Univ, Gil Med Ctr, Dept Internal Med, Coll Med,Div Cardiol, Incheon, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Lee, Sang Ah Lee, SA 25 Jeju Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Jeju, South Korea O-8501-2017 Lee, Sang leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, Yong-Hyun Kim, YH 26 Bundang Jesaeng Hosp, Div Endocrinol & Metab, Dept Internal Med, Seongnam, South Korea AAA-2134-2022 Kim, Yong Won leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, Kyung-Soo Kim, KS 27 CHA Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab,CHA Bundang Med Ctr, Seongnam, South Korea JMC-2134-2023 Kim, Bo Kyung leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Seo, Ji A. Seo, JA 28 Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Ansan Hosp, Ansan, South Korea AAU-7968-2020 SEO, JI leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Nam-Goong, Il Seong Nam-Goong, I 29 Univ Ulsan, Div Endocrinol & Metab, Dept Internal Med, Ulsan Univ Hosp,Coll Med, Ulsan, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Lee, Chang Won Lee, CW 30 Busan St Marys Hosp, Dept Internal Med, Div Endocrinol & Metab, Busan, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, Duk Kyu Kim, DK 31 Dong A Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med,Dong A Univ Hosp, Busan, South Korea leemk4132@gmail.com;
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial Kim, Sang Wook Kim, SW 32 Kangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Dept Internal Med,Div Endocrinol & Metab, Chunchon, South Korea leemk4132@gmail.com;
페이지 이동: